Text Module

Share

Program Content

Activities

  • CLL BTK Inhibitor Tx and AE Guide
    Global Perspectives and Clinical Resources to Guide Treatment Decisions and Management of Adverse Events With BTK Inhibitor Therapy in CLL 
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: March 13, 2025

    Expires: September 12, 2025

Provided by

ProCE Banner

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca